MENU
+Compare
GILD
Stock ticker: NASDAQ
AS OF
Nov 13, 04:59 PM (EDT)
Price
$125.26
Change
+$1.86 (+1.51%)
Capitalization
155.33B

GILD Gilead Sciences Forecast, Technical & Fundamental Analysis

Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C... Show more

Industry: #Biotechnology
GILD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for GILD with price predictions
Nov 12, 2025

Momentum Indicator for GILD turns positive, indicating new upward trend

GILD saw its Momentum Indicator move above the 0 level on November 11, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 86 similar instances where the indicator turned positive. In of the 86 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The 10-day moving average for GILD crossed bullishly above the 50-day moving average on October 13, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GILD advanced for three days, in of 328 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for GILD moved out of overbought territory on October 22, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Moving Average Convergence Divergence Histogram (MACD) for GILD turned negative on November 07, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 57 similar instances when the indicator turned negative. In of the 57 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GILD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.210) is normal, around the industry mean (9.612). P/E Ratio (19.381) is within average values for comparable stocks, (23.835). Projected Growth (PEG Ratio) (0.228) is also within normal values, averaging (2.037). Dividend Yield (0.025) settles around the average of (0.028) among similar stocks. P/S Ratio (5.432) is also within normal values, averaging (3.560).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. GILD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
GILD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

GILD is expected to report earnings to fall 21.86% to $1.93 per share on February 10

Gilead Sciences GILD Stock Earnings Reports
Q4'25
Est.
$1.93
Q3'25
Beat
by $0.32
Q2'25
Beat
by $0.05
Q1'25
Beat
by $0.04
Q4'24
Beat
by $0.19
The last earnings report on October 30 showed earnings per share of $2.47, beating the estimate of $2.15. With 9.25M shares outstanding, the current market capitalization sits at 155.33B.
A.I.Advisor
published Dividends

GILD paid dividends on September 29, 2025

Gilead Sciences GILD Stock Dividends
А dividend of $0.79 per share was paid with a record date of September 29, 2025, and an ex-dividend date of September 15, 2025. Read more...
A.I. Advisor
published General Information

General Information

a developer of therapeutic products and treatments for life threatening diseases

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Biotechnology
Address
333 Lakeside Drive
Phone
+1 650 574-3000
Employees
18000
Web
https://www.gilead.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
JETS25.690.77
+3.09%
US Global Jets ETF
GLDM83.051.30
+1.59%
SPDR® Gold MiniShares
ALITF17.00N/A
N/A
ALLIANCE WITAN PLC
BTR25.38N/A
N/A
Beacon Tactical Risk ETF
FCAL49.44-0.05
-0.09%
First Trust California Muni Hi Inc ETF

GILD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GILD has been loosely correlated with BMY. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if GILD jumps, then BMY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GILD
1D Price
Change %
GILD100%
+0.69%
BMY - GILD
46%
Loosely correlated
+0.74%
AMGN - GILD
44%
Loosely correlated
-0.64%
NVS - GILD
43%
Loosely correlated
+1.37%
GSK - GILD
42%
Loosely correlated
-0.70%
PFE - GILD
38%
Loosely correlated
+1.41%
More